Suppr超能文献

修订版马凡综合征根特分类法。

The revised Ghent nosology for the Marfan syndrome.

机构信息

Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, Gent, Belgium.

出版信息

J Med Genet. 2010 Jul;47(7):476-85. doi: 10.1136/jmg.2009.072785.

Abstract

The diagnosis of Marfan syndrome (MFS) relies on defined clinical criteria (Ghent nosology), outlined by international expert opinion to facilitate accurate recognition of this genetic aneurysm syndrome and to improve patient management and counselling. These Ghent criteria, comprising a set of major and minor manifestations in different body systems, have proven to work well since with improving molecular techniques, confirmation of the diagnosis is possible in over 95% of patients. However, concerns with the current nosology are that some of the diagnostic criteria have not been sufficiently validated, are not applicable in children or necessitate expensive and specialised investigations. The recognition of variable clinical expression and the recently extended differential diagnosis further confound accurate diagnostic decision making. Moreover, the diagnosis of MFS--whether or not established correctly--can be stigmatising, hamper career aspirations, restrict life insurance opportunities, and cause psychosocial burden. An international expert panel has established a revised Ghent nosology, which puts more weight on the cardiovascular manifestations and in which aortic root aneurysm and ectopia lentis are the cardinal clinical features. In the absence of any family history, the presence of these two manifestations is sufficient for the unequivocal diagnosis of MFS. In absence of either of these two, the presence of a bonafide FBN1 mutation or a combination of systemic manifestations is required. For the latter a new scoring system has been designed. In this revised nosology, FBN1 testing, although not mandatory, has greater weight in the diagnostic assessment. Special considerations are given to the diagnosis of MFS in children and alternative diagnoses in adults. We anticipate that these new guidelines may delay a definitive diagnosis of MFS but will decrease the risk of premature or misdiagnosis and facilitate worldwide discussion of risk and follow-up/management guidelines.

摘要

马凡综合征(MFS)的诊断依赖于明确的临床标准(根特分类法),由国际专家意见制定,旨在促进对这种遗传性动脉瘤综合征的准确识别,并改善患者的管理和咨询。这些根特标准包括一系列主要和次要的临床表现,涉及不同的身体系统,事实证明,自采用分子技术以来,这些标准效果良好,因为超过 95%的患者可以通过这些标准来确认诊断。然而,当前分类法存在一些问题,即一些诊断标准尚未得到充分验证,不适用于儿童,或者需要昂贵和专门的检查。对可变临床表达的认识以及最近扩展的鉴别诊断进一步混淆了准确的诊断决策。此外,MFS 的诊断——无论是否正确确立——都可能带有污名,阻碍职业抱负,限制人寿保险机会,并造成心理社会负担。一个国际专家小组制定了修订后的根特分类法,该分类法更注重心血管表现,其中主动脉根部瘤和晶状体异位是主要的临床特征。如果没有家族史,存在这两种表现就足以明确诊断 MFS。如果不存在这两种表现,就需要存在真正的 FBN1 突变或全身性表现的组合。对于后者,已经设计了一个新的评分系统。在这个修订后的分类法中,虽然 FBN1 检测不是强制性的,但在诊断评估中具有更大的权重。对于儿童 MFS 的诊断和成人的替代诊断,都有特殊的考虑。我们预计这些新指南可能会延迟 MFS 的明确诊断,但会降低过早或误诊的风险,并促进全球范围内对风险和随访/管理指南的讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验